The interplay between endometriosis and obesity
- PMID: 40280861
- PMCID: PMC12439108
- DOI: 10.1016/j.tem.2025.03.011
The interplay between endometriosis and obesity
Abstract
Endometriosis, characterized by uterine-like tissue growth outside the uterus, is a complex disorder with significant clinical implications. This review explores how body composition - both low body mass index (BMI) and obesity - modulates endometriosis progression through metabolic, hormonal, and immune-inflammatory pathways. Obesity-driven leptin signaling emerges as a pivotal link, promoting systemic inflammation, angiogenesis, and lesion persistence via Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathways. Shared molecular mechanisms between endometriosis and obesity highlight opportunities for precision medicine and targeted therapies. By addressing leptin-driven pathways and metabolic dysfunction, we introduce innovative strategies, offering novel insights into the improved management of this multifaceted condition.
Keywords: BMI; body composition; endometriosis; leptin; obesity.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
References
-
- Bonavina G and Taylor HS (2022) Endometriosis-associated infertility: From pathophysiology to tailored treatment. Front Endocrinol (Lausanne) 13, 1020827. 10.3389/fendo.2022.1020827 - DOI
-
- Reis JL et al. (2022) Natural Killer Cell Receptors and Endometriosis: A Systematic Review. Int J Mol Sci 24. 10.3390/ijms24010331 - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
